334 CAR T engagers encoding immune checkpoint inhibitors and immune-relevant cytokines stimulate CAR T cell activity against hematologic and solid tumors

Abstract

BackgroundCell therapeutics are limited by critical issues including antigen escape, antigen heterogeneity, tumor and tumor microenvironment mediated immune suppression and suboptimal T cell expansion, fitness and persistence. We originally created...